Biofarma GroupVice President of Human Resources
Feb. 2022 - Feb. 2025North Brunswick, New Jersey, United States• Trusted strategic advisor to the C-suite, leading HR functions and contributing to other critical business areas.
• Scaled workforce from 150 to 450 employees in 2 years during COVID, formalizing HR processes, implementing systems, and establishing KPIs..
• Led the successful implementation of an HRIS (ADP) including vendor selection and system management while collaborating with executives to ease transition concerns and create a data-driven HR Organization. • Overhauled the Payroll Process to enhance accuracy and trained team members in payroll responsibilities using an analytical approach. • Reduced turnover from 37% to 18% by connecting employee performance with value propositions, leading to a 40% increase in EBITDA.
• Redesigned global onboarding, talent management, and career pathing post-acquisition, supporting 1,500 staff and prioritizing DE&I initiatives.
• Created communication and change management strategies to drive large-scale transformations, improving transparency and building trust-based relationships.
• Increased retention rates by 41% through stay interviews and operational framework modifications.
• Improved leadership pipelines with targeted development programs, increasing internal promotions by 8% and reducing employee attrition from 29% to 14%.
• Accelerated GTM strategy launch from 18 months to 6 months by streamlining project portfolios and focusing on high-value opportunities.
• Negotiated employee benefits contracts, reducing healthcare costs by 10%, and optimized the HR budget, cutting operational expenses by 15%.
• Leveraged data-driven strategies to foster a unified culture and functional excellence across 3 countries.
• Enhanced M&A integration by dissolving siloes, fostering brand pride, and launching a mission-driven ecosystem that increased revenue growth by 20%.
• Developed a human capital strategy, predicting future talent needs and achieving an 11% reduction in people-related spend.